An Act including Krabbe Disease in newborn screening
Massachusetts bill mandates newborn screening for Krabbe disease to enable early detection and treatment intervention for this rare, progressive neurological disorder.
Massachusetts bill mandates newborn screening for Krabbe disease to enable early detection and treatment intervention for this rare, progressive neurological disorder.
HD 3570 would mandate that Massachusetts include Krabbe disease in its newborn screening program. Krabbe disease is a rare, inherited metabolic disorder that causes progressive neurological deterioration. The bill would require all newborns in Massachusetts to be tested for this condition at birth.
Early detection of Krabbe disease can enable treatment interventions that may slow or prevent severe neurological damage, potentially preserving quality of life and reducing healthcare costs. Currently, many cases go undetected until symptoms appear, at which point significant irreversible damage has occurred. Adding the test to mandatory screening increases the likelihood of identifying affected infants during the critical window for treatment.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.